SGIE 2024/25 Report Shows Rise in Pharma and Halal Certification

The latest Singapore Global Innovation Exchange (SGIE) 2024/25 report reveals significant developments in two key sectors: pharmaceutical manufacturing and halal certification. These trends reflect important shifts in global markets, with countries prioritizing medicine security and businesses adapting to growing consumer demand for certified products.

Expansion of Local Pharmaceutical Capabilities

The COVID-19 pandemic exposed vulnerabilities in global medicine supply chains, prompting nations worldwide to strengthen their domestic pharmaceutical industries. This strategic move aims to reduce dependence on imports and ensure stable access to essential medications.

Key Drivers of Growth

• Government incentives like tax breaks and funding for research

• Technological advancements in biotech and AI-driven drug development

  Be the first to get new Halal products & exclusive brand reviews!

  
  

  Subscribe

  Loading...

  Subscribe

  Loading...

  Thank you!

  You have successfully joined our subscriber list.

• Increased investment in vaccine and generic medicine production

• Supply chain diversification to prevent future shortages

Countries across Asia and the Middle East are leading this transformation. Singapore has emerged as a biotech hub, while Saudi Arabia’s Vision 2030 plan includes major pharmaceutical investments. In Southeast Asia, Malaysia and Indonesia are expanding their production capabilities for both branded and generic drugs.

The report highlights how new technologies are making local production more efficient. Artificial intelligence now helps researchers develop drugs faster, while advanced manufacturing techniques allow for smaller, more flexible production facilities. These innovations are particularly important for developing countries looking to build their pharmaceutical industries.

Challenges and Opportunities

While the growth potential is significant, some obstacles remain. Establishing modern pharmaceutical facilities requires substantial investment, and many regions face shortages of trained professionals. However, international partnerships and training programs are helping address these issues.

The future looks promising, with several emerging trends:

• Increased collaboration between governments and private companies

• Greater focus on producing medicines for regional health needs

• Development of sustainable manufacturing practices

• Expansion of biotechnology research centers

Rising Demand for Halal Certification

Halal certification is experiencing remarkable growth, extending far beyond its traditional food sector applications. The SGIE report documents how this Islamic compliance standard is now being applied to pharmaceuticals, cosmetics, and even logistics services.

Market Expansion Factors

• Growing Muslim population with increasing purchasing power

• New government regulations requiring halal certification

• Consumer awareness about product ingredients and origins

• Technological solutions for certification verification

The global halal market is projected to reach $2.8 trillion by 2025, with Southeast Asia and the Middle East leading the way. Malaysia remains the world’s top halal exporter, while the United Arab Emirates has established itself as a certification hub through its Halal Certification Centre.

Emerging Halal Sectors

The report identifies several industries experiencing rapid halal certification growth:

1. Pharmaceuticals – Demand for medicines without alcohol or animal-derived ingredients

2. Cosmetics – Beauty products free from prohibited substances

3. Logistics – Specialized transportation to prevent contamination

4. Finance – Sharia-compliant banking and insurance products

Digital verification methods are making certification more accessible. Blockchain technology now allows consumers to scan QR codes and instantly verify a product’s halal status, increasing transparency throughout the supply chain.

Future Developments

Industry experts predict several important trends:

• Standardization of global halal certification requirements

• Development of lab-grown halal meat alternatives

• Expansion of halal tourism services

• Increased investment in halal research and development

Strategic Implications for Businesses

The SGIE report emphasizes that companies adapting early to these trends will gain significant competitive advantages. Pharmaceutical firms investing in local production can benefit from government incentives and secure stable market positions. Businesses obtaining halal certification open doors to rapidly growing consumer markets.

For pharmaceutical companies, the key strategies include:

• Partnering with research institutions

• Investing in workforce training

• Adopting sustainable production methods

• Developing products tailored to regional health needs

Businesses pursuing halal certification should:

• Understand specific market requirements

• Implement transparent supply chains

• Leverage digital verification tools

• Educate consumers about certification benefits

The SGIE 2024/25 report paints a picture of significant transformation in these two important sectors. As nations prioritize medicine security and consumers increasingly demand certified products, businesses have substantial opportunities for growth. The coming years will likely see continued expansion in both local pharmaceutical production and halal certification across multiple industries.

Companies that recognize these trends early and adapt their strategies accordingly will be best positioned to succeed in these evolving markets. The report serves as both a roadmap for business planning and a warning against complacency in rapidly changing economic landscapes.